Arteris, Inc. key statistics and ratios
In fiscal 2025, Arteris, Inc. had an operating margin of -47.0% and a current ratio of 1.13. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Gross margin | 95.3% | 90.1% | 91.5% | 90.5% | 89.7% | 90.2% | 87.6% |
| Operating margin | −11.9% | −57.5% | −57.3% | −65.5% | −54.7% | −47.0% | −47.7% |
| Net margin | −10.2% | −61.8% | −54.4% | −68.7% | −58.3% | −49.2% | −46.7% |
| Free-cash-flow margin | 4.7% | −4.3% | −15.5% | −32.1% | −1.8% | 7.6% | 8.0% |
| Return on equity | — | −114.4% | −60.6% | −140.1% | — | — | −149.0% |
| Return on assets | −7.6% | −28.7% | −23.2% | −33.8% | −32.2% | −31.4% | −23.3% |
| Asset turnover | 0.74 | 0.46 | 0.43 | 0.49 | 0.55 | 0.64 | 0.50 |
| Current ratio | 1.03 | 2.51 | 1.86 | 1.26 | 1.17 | 1.13 | 1.57 |
| Debt to equity | — | 0.0% | 0.0% | 0.0% | — | — | 0.0% |
| Interest cover (operating income ÷ interest) | n/m | n/m | n/m | n/m | n/m | n/m | n/m |
| R&D as % of revenue | 53.5% | 81.4% | 81.7% | 84.1% | 78.0% | 70.7% | 67.5% |
| Capital spending as % of revenue | 2.1% | 2.1% | 2.1% | 2.8% | 0.6% | 2.0% | 2.1% |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 90.1% | 89.8% | 90.8% | 89.4% | 89.9% | 90.8% | 85.8% | 85.1% |
| Operating margin | −53.8% | −45.9% | −46.6% | −50.0% | −50.1% | −42.0% | −40.5% | −57.6% |
| Net margin | −52.2% | −53.0% | −49.1% | −55.3% | −51.6% | −42.2% | −34.7% | −58.3% |
| Free-cash-flow margin | 7.4% | −17.3% | 16.2% | −17.2% | 14.2% | 15.1% | −32.1% | 35.7% |
| Current ratio | 1.16 | 1.17 | 1.02 | 0.98 | 0.91 | 1.13 | 0.73 | 1.57 |
| R&D as % of revenue | 81.0% | 74.5% | 71.8% | 73.8% | 72.7% | 65.7% | 63.0% | 69.5% |
Financial health
- Short-term assets cover short-term liabilities $146m of assets due within a year against $93m of liabilities due within a year.
- Short-term assets cover long-term liabilities $146m short-term assets against $64m of longer-dated liabilities.
- More cash than debt Cash or debt not separately reported. Not assessable.
- Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
- Operating profit covers interest at least five times over Operating income of −$40m against $171,000 of interest.
Moat
Moderate moat
How hard Arteris's competitive advantage looks for rivals to wear away, judged from 6 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 20 / 20
Cash operating profit has been a median 20.2% of total assets over 5 years.
- Pricing power 20 / 20
Gross margin has been a median 90.5%, moving by 1.9 percentage points (standard deviation) across 6 years.
- Durability 10 / 20
Operating margin has been a median -49.9%; its worst year was -66.3%.
- Cash conversion 2 / 20
Free cash flow was positive in 1 of 5 years, at a median -2.8% of revenue.
AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.
Compare with peers
- Valens Semiconductor Ltd. statistics
- Everspin Technologies Inc. statistics
- Ceva Inc statistics
- Navitas Semiconductor Corp statistics
- Indie Semiconductor, Inc. statistics
Head to head: AIP vs VLNAIP vs MRAMAIP vs CEVA
More: Semiconductors stocks compared, Technology sector, rankings of US companies